Xenon Pharmaceuticals Inc (NASDAQ:XENE)

15.84
Delayed Data
As of Sep 21
 -0.48 / -2.95%
Today’s Change
9.32
Today|||52-Week Range
21.94
+2.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues15.6M1.8M311.0K0.00
 
 
 
 
Depreciation And Amortization1.0M864.0K649.0K586.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------586.0K
 
 
General Expenses23.9M25.8M32.2M31.4M
 
 
 
 
 
Research And Development15.2M19.8M25.6M23.6M
 
 
 
 
 
Total Operating Expenses24.9M26.6M32.9M32.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.4M-24.8M-32.6M-32.0M
 
 
 
 
 
Extraordinary Charge0.000.000.00-1.6M
 
 
Interest Expense On Debt0.000.00--1.4M
 
 
Other Expenses-6.9M1.3M1.4M-701.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.8M-23.0M-30.7M-34.5M
 
 
 
 
 
Preferred Dividend0.000.000.00-2.9M
 
 
Net Income-15.8M-23.0M-30.7M-34.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.3M15.5M18.0M19.4M
 
 
 
 
 
Shares To Calculate EPS Diluted14.3M15.5M18.0M19.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.10-$1.48-$1.71-$1.63
 
 
 
 
 
EPS Diluted-$1.10-$1.48-$1.72-$1.63